This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jan. 29, 2013




















 

FDA approves 3 new drugs for Type 2 diabetes
HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administration recently approved three new medications to help people battle Type 2 diabetes. All three drugs contain a new active ingredient, alogliptin, either alone or in combination with other, previously approved medications. The newly approved drugs include Nesina, Kazano and Oseni, the FDA said in a news release. More



 Area and Association News


Call for candidates: USP Expert Panel on General Chapter <797> Pharmaceutical Compounding — Sterile Preparations
U.S. Pharmacopeial Convention    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Posting Date: Jan. 11
Closing Date: March 1
Expert Committee: General Chapters: Healthcare Quality Standards — Compounding Expert Committee
USP invites qualified candidates to serve on the Pharmaceutical Compounding – Sterile Preparations Expert Panel. The purpose of this Expert Panel will be to aid in the revision of USP-NF General Chapter <797> Pharmaceutical Compounding-Sterile Preparations.
Gigi Davidson, B.S. Pharm., DICVP, the current Chair of the USP Compounding Expert Committee, and will work at the direction of the Compounding Expert Committee and present revision recommendations for evaluation and approval.
–Sterile Preparations. In response, the Expert Panel will review, evaluate, and make suggested revisions for:
  • Defining the scope and audience of the chapter;
  • Assessing chapter organization;
  • Assessing microbial contamination risk levels;
  • Establishing appropriate levels/quantities of preparations to be tested for identity, strength, purity, and sterility;
  • Identifying quality measures for outsourced responsibilities;
  • Clarifying environmental quality and control practices;
  • Assisting with additional requests from the Compounding Expert Committee.
Expertise needed for this Expert Panel include but are not limited to: Compounding Practitioners, Pharmacy Educators, Human Factors Engineers, Infection Control Specialists, Quality Control Specialists, Environmental Engineers, and experts in Nuclear Medicine, Microbiology, and Industrial Hygiene.
Staff support resides in the USP's Healthcare Quality Standards Group. USP anticipates establishing the Expert Panel by March 15. The work of the Expert Panel will be conducted via webex and teleconference meetings at a frequency to be determined based on need. A face-to-face meeting at USP headquarters in Rockville, Md., may also be scheduled.
Apply for this Expert Panel
Learn more about the role of USP Expert Panels in the standards setting process
For additional information, contact Rick Schnatz, Senior Scientific Liaison, Compounding (rxs@usp.org or 301-816-8526).
More

Seeking input from pharmacists on the state of antiviral medication supplies
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
We are seeking input from pharmacists regarding the current state of antiviral medication supplies across the country. This information will be shared with the CDC and other public health partners. We would appreciate your providing an update on the current environment your practice(s) are experiencing. This is a short survey containing 9 questions. Results will be reported in the aggregate and individual responses will be kept confidential. Thank you in advance for your prompt response. Click here to complete the survey.

AHCCCS Bulletin: Pharmacy claims processing BINs, PCNs and Group Numbers
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The purpose of this memo is to provide 340B Contract Pharmacies and 340B Pharmacy Contract Administrators with an updated list of the AHCCCS Fee-For-Service Program and the Managed Care Contractors' PBMs', BINs, PCNs and Group Numbers if applicable. More

Not an AzPA member? Join today
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings. With over 1,500 members, we are a leading association of pharmacists spreading the news and events of our industry. More

 Pharmacy Updates


ACLU: Walgreens assures on birth control pill policy
The Associated Press via Crain's Chicago Business    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Walgreen Co. won't allow individual pharmacists' personal religious beliefs to prevent customers from filling birth control prescriptions, two New Mexico advocacy groups have announced. The Deerfield, Ill.-based company told the American Civil Liberties Union and the Southwest Women's Law Center that the company will take steps nationwide to make sure customers received prescriptions regardless of employees' beliefs, ACLU of New Mexico said in a recent statement. More

Judge freezes owners' assets for pharmacy blamed in meningitis outbreak
The Associated Press via WFMY-TV    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A bankruptcy court judge has frozen the assets of the owners of a Massachusetts pharmacy blamed for a deadly meningitis outbreak. Judge Henry Boroff's recent order at a hearing in Springfield, Mass., forbids the owners of the New England Compounding Center from spending or moving their assets, except to pay living expenses or legal bills. More

 In the News


Canadian pharmacy dispenses with convention to sell organic, healthy foods
Ottawa Citizen    Share    Share on FacebookTwitterShare on LinkedinE-mail article
If you wanted to buy some fresh filet mignon, frozen lake trout or gluten-free gnocchi, a drugstore probably wouldn't be the first place you'd think of. But in Westboro, Canada, the neighborhood pharmacy now stocks all those things and more. About 18 months ago, Westboro Village Pharmasave removed its cosmetics, candy bars and Coke and turned over one-quarter of the store to healthy foods. "We said, 'You know what, let's be different,'" says Mark Barnes, pharmacy manager and co-owner of the store. "We decided that if we're going to be health promoters in the pharmacy, we want to be health promoters in the front store, too. As far as I know, we're the only pharmacy to do this." More

It's time to take charge
Pharmacy Practice News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
As healthcare reform moves forward, all pharmacists need to understand how payment mechanisms for outpatient services are determined. Why not just leave this task to your billing and coding team or to some administrative person in your department? One compelling factor is the system that the Centers for Medicare & Medicaid Services use to determine payments. CMS bases its policies primarily on how your staff decides to choose and use a medication — and the degree to which your staff accurately documents those treatment decisions. Moreover, new payment mechanisms are built on a platform of data from previous years. So if your systems and records are less than stellar, you'll be contributing to a new program that underestimates true costs of care. More

 Medication Updates


Recommendations for influenza antiviral medications
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Alicia Fry, medical epidemiologist in the Influenza Division at the Centers for Disease Control, recently spoke as part of the CDC Expert Commentary Series on Medscape. Fry states, "This influenza season has been characterized by early and intense flu activity throughout much of the country, and CDC continues to recommend annual vaccination as the best tool for preventing influenza." In her speech, she discusses vaccination and treatment to control the spread of influenza this season. More

1st OTC drug approved for women with overactive bladder
HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The drug Oxytrol has been approved by the Food and Drug Administration as the first over-the-counter treatment for women 18 and older with overactive bladder. Oxytrol contains oxybutynin, among a class of drugs called anticholinergics that are designed to relax the bladder muscle. Oxytrol is a patch applied to the skin every four days, the FDA said in a news release. More

NSAIDS and skin cancer: Reduced risk?
Pharmacy Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Numerous studies have been conducted to determine whether nonsteroidal anti-inflammatory drugs are associated with a decreased risk of cancer. The proposed mechanisms include cyclooxygenase inhibitions leading to decreased apoptosis, immunosuppression or changes in angiogenesis and the ability to invade normal tissue. Most research has focused on colorectal cancer, but squamous cell carcinoma, basal cell carcinoma and malignant melanoma are also of interest. SCC is closely associated with actinic keratosis, whereas BCC and MM are more closely linked to sun exposure and skin damage. More

FDA warns: Tolvaptan poses risk for serious liver damage
Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Tolvaptan, indicated for treating clinically significant hypervolemic and euvolemic hyponatremia, poses the risk of causing irreversible and potentially fatal liver injury, the Food and Drug Administration recently announced. Clinicians should perform liver tests as soon as possible in patients who report fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice or any other symptom that may suggest liver injury, the FDA said. Patients suspected of having liver injury should stop receiving Tolvaptan immediately. More


 

AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Content Editor, 469.420.2696   
Contribute news

Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Jan. 29, 2013
Jan. 22, 2013
Jan. 15, 2013
Jan. 8, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063